Brookstone Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $993K | Sell |
1,980
-6,506
| -77% | -$3.12M | 0.01% | 700 |
|
|
2026
Q1 | $4.17M | Sell |
8,486
-62
| -0.7% | -$33.6K | 0.05% | 353 |
|
|
2025
Q4 | $4.95M | Buy |
8,548
+96
| +1% | +$54.3K | 0.06% | 311 |
|
|
2025
Q3 | $4.1M | Sell |
8,452
-471
| -5% | -$219K | 0.05% | 334 |
|
|
2025
Q2 | $3.62M | Buy |
8,923
+795
| +10% | +$332K | 0.05% | 325 |
|
|
2025
Q1 | $4.04M | Buy |
8,128
+5,798
| +249% | +$3.14M | 0.06% | 298 |
|
|
2024
Q4 | $1.21M | Sell |
2,330
-228
| -9% | -$125K | 0.02% | 478 |
|
|
2024
Q3 | $1.58M | Buy |
2,558
+76
| +3% | +$45K | 0.02% | 421 |
|
|
2024
Q2 | $1.38M | Sell |
2,482
-1,905
| -43% | -$1.09M | 0.02% | 434 |
|
|
2024
Q1 | $2.55M | Buy |
4,387
+3,142
| +252% | +$1.76M | 0.05% | 321 |
|
|
2023
Q4 | $661K | Sell |
1,245
-1,812
| -59% | -$877K | 0.01% | 540 |
|
|
2023
Q3 | $1.44M | Sell |
3,057
-624
| -17% | -$333K | 0.03% | 364 |
|
|
2023
Q2 | $1.89M | Buy |
3,681
+187
| +5% | +$101K | 0.04% | 316 |
|
|
2023
Q1 | $2.06M | Sell |
3,494
-153
| -4% | -$86.2K | 0.04% | 320 |
|
|
2022
Q4 | $1.95M | Sell |
3,647
-274
| -7% | -$145K | 0.04% | 321 |
|
|
2022
Q3 | $1.96M | Buy |
3,921
+120
| +3% | +$67.2K | 0.05% | 292 |
|
|
2022
Q2 | $2.1M | Sell |
3,801
-370
| -9% | -$204K | 0.05% | 282 |
|
|
2022
Q1 | $2.44M | Sell |
4,171
-409
| -9% | -$235K | 0.05% | 265 |
|
|
2021
Q4 | $2.78M | Buy |
4,580
+245
| +6% | +$153K | 0.05% | 224 |
|
|
2021
Q3 | $2.49M | Buy |
4,335
+151
| +4% | +$82.9K | 0.04% | 235 |
|
|
2021
Q2 | $2.15M | Buy |
4,184
+2,554
| +157% | +$1.21M | 0.04% | 252 |
|
|
2021
Q1 | $744K | Sell |
1,630
-638
| -28% | -$305K | 0.03% | 289 |
|
|
2020
Q4 | $1.06M | Sell |
2,268
-248
| -10% | -$116K | 0.04% | 224 |
|
|
2020
Q3 | $1.11M | Buy |
2,516
+578
| +30% | +$239K | 0.05% | 200 |
|
|
2020
Q2 | $702K | Buy |
1,938
+1,030
| +113% | +$345K | 0.04% | 197 |
|
|
2020
Q1 | $258K | Sell |
908
-363
| -29% | -$114K | 0.01% | 275 |
|
|
2019
Q4 | $413K | Buy |
1,271
+167
| +15% | +$50.6K | 0.02% | 300 |
|
|
2019
Q3 | $322K | Sell |
1,104
-4
| -0.4% | -$1.15K | 0.02% | 327 |
|
|
2019
Q2 | $325K | Sell |
1,108
-136
| -11% | -$37.5K | 0.02% | 355 |
|
|
2019
Q1 | $341K | Buy |
+1,244
| New | +$310K | 0.02% | 318 |
|
|
2018
Q4 | – | Sell |
-831
| Closed | -$203K | – | 397 |
|
|
2018
Q3 | $203K | Buy |
+831
| New | +$191K | 0.02% | 386 |
|
|
2018
Q2 | – | Sell |
-975
| Closed | -$201K | – | 409 |
|
|
2018
Q1 | $201K | Buy |
+975
| New | +$205K | 0.02% | 331 |
|
|
2015
Q4 | – | Sell |
-229
| Closed | -$28K | – | 815 |
|
|
2015
Q3 | $28K | Hold |
229
| – | – | 0.01% | 616 |
|
|
2015
Q2 | $30K | Buy |
+229
| New | +$29.9K | ﹤0.01% | 663 |
|
Other funds holding TMO
Brookstone Capital Management's TMO Position: Q2 2026 in Review
Brookstone Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 77% in Q2 2026, selling an estimated $3.12M and leaving 1,980 shares worth $993K. The position accounts for 0.01% of the portfolio, ranked #700.
Brookstone Capital Management first reported a position in TMO in Q2 2015 and has held it in 34 quarters since. The position peaked at $4.95M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Brookstone Capital Management held 1,980 shares of Thermo Fisher Scientific worth $993K as of Q2 2026.
- Brookstone Capital Management sold 6,506 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.12M.
- Thermo Fisher Scientific made up 0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #700 holding.
- Brookstone Capital Management first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 34 quarters since.
- Brookstone Capital Management's Thermo Fisher Scientific position peaked at $4.95M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.